Drug Discovery 2019 - Looking back to the future

Speakers

Invited Speakers

Paul Andrews
National Phenotypic Screening Centre
Dr David Andrews
AstraZeneca
Prof John Atack
Medicines Discovery Institute
Keriann Backus
UCLA
Marcus Bantscheff
Cellzome A GSK company
Prof Michael Barnes
Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of
Dr Chantal Bazenet
Evotec
Dr Emma Beale
Diamond Light Source Ltd.
Sara Buhrlage
Dana-Farber Cancer Institute
Rosemary Burke
The Institute of Cancer Research
Hugo Ceulemans
Janssen Pharmaceutica
Chun-wa Chung
GSK
Prof Alessio Ciulli
University of Dundee
Paul Clarke
ICR
Werngard Czechtizky
AstraZeneca
Dr Tom Davies
Astex Pharmaceuticals
Prof Charlotte Deane
Department of Statistics, University of Oxford
Ms Florijn Dekkers
Princess Máxima Centre
Ola Engkvist
AstraZeneca
Stuart Farrow
CR-UK Therapeutic Discovery Laboratories
Stuart Francis
The Beatson Institute for Cancer Research
Dr Kelly Gatfield
GSK
Sam Genway
Tessella
Prof David Gray
University of Dundee
Philip Gribbon
Fraunhofer IME ScreeningPort
Maria Groves
Cancer Research UK-MedImmune Alliance Laboratory
Mr Gregory Hamm
AstraZeneca
Tim Hammonds
CRUK TDL
Dr Ian Hardcastle
Newcastle University
Michael Hennig
leadXpro AG
Dr John Hutchison
Autifony
David Kendall
Pharmnovo
Catherine Kettleborough
LifeArc
Dr Bon-Kyoung Koo
IMBA - Institute of Molecular Biotechnology of Austrian Academy of Sciences
Austria
Matthias Lauer
F. Hoffmann - La Roche Ltd
Dr Melanie Lee
LifeArc
Timm Maier
Biozentrum, University of Basel
Andrea Malaspina
Blizard Institute, QMUL
Dr Martina Marchetti-Deschmann
TU Wien, Institute of Chemical Technologies and Analytics
Austria
Dr Fiona Marshall
MSD
Prof Alistair Mathie
University of Kent
Dr Heather McKinnon
Beatson
Guillaume Mondésert
Evotec
Sarah Nickolls
GlaxoSmithKline
Greg Osborne
Sosei Heptares
Peter O'Toole
University of York
Mene Pangalos
AstraZeneca
Saradhav Pathy
National University of Singapore
Dr Ian Pike
Ian Pike Consulting
Prof Steven Pollard
University of Edinburgh
Sally Price
Medicines Discovery Catapult
Ali Raoof
Cancer Research UK Manchester Institute
Steve Rees
AstraZeneca
Wendy Rowan
GlaxoSmithKline
Prof Gary Stephens
University of Reading
Dr Rob Van Montfort
The Institute of Cancer Research
Satpal Virdee
University of Dundee
Dr Robert Vries
Hubrecht Organoid Technology
Louise Walport
The Francis Crick Institute/Imperial College London
Prof Paul Workman
The Institute of Cancer Research, London.
Paul Wright
LifeArc

Speakers

Dr Simon Cruwys
TherapeutAix
Germany
Mr Thomas Fleming
Arctoris
Dr Matthias Gossmann
innoVitro GmbH
Germany
Dr Zachary Gurard-Levin
SAMDI Tech, Inc.
United States
Jenna Kenyani
University of Liverpool
Dr Isabel M Caballero
Pelago Bioscience AB
Sweden
Dr Sophia Malandraki-Miller
University of Oxford
Dr James Noble
National Physical Laboratory
Dr Alison Obergrussberger
Nanion Technologies GmbH
Germany
Hiren Patel
CytoSMART Technologies B.V.
Netherlands
Dr Arwa Raies
European Bioinformatics Institute (EMBL-EBI)
Dr Brent Ryan
University of Oxford
Dr Christoph Sachse
NMI TT Pharmaservices
Germany
Miss Afrah Sattikar
LifeArc
Miss Rachel Sim
University of Oxford
Dr Frank Staubli
Nebion AG
Switzerland
Dr Graeme Walker
Cancer Research UK Manchester Institute
Dr David Walter
Cancer Research UK–AstraZeneca Functional Genomics Centre
Sponsor